Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies



Rating:

Share or cite this content

Citations should be made in the following way:
M. Oliver (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom), S. Couillard (Oxford, United Kingdom). Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis. 3741

Member's Comments

No comment yet.

Related content which might interest you: Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009 Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Repeated medical visits in asthma patients: Results from the L777 observational study Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 The value of additional testing in physician diagnosed asthma: A prospective pilot study Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management Year: 2012 Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data Source: ERJ Open Res, 3 (2) 00085-2016; 10.1183/23120541.00085-2016 Year: 2017 Do picture charts improve the accuracy of asthma medication history given by parents? A prospective cohort study Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 What predicts poor collection of medication among children with asthma? A case-control study Source: Eur Respir J 2002; 20: 1464-1469 Year: 2002 Costs and effects of structured COPD care – An observational, matched-cohort study Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 The APEX study: A retrospective review of outcomes in patients with severe allergic asthma who were or were not hospitalised in the year prior to omalizumab initiation in UK clinical practice Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Clustering of COPD patients admitted to pulmonary rehabilitation: a retrospective cohort analysis Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD Year: 2021 Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Metabolomic approach in the characterization of omalizumab responders and non-responders among children with severe asthma: a multicenter prospective study. Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021